Report cover image

Global Cell and Gene Therapy CRO Service Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Dec 23, 2023
Length 113 Pages
SKU # LPI18406465

Description

Global Cell and Gene Therapy CRO Service Market Growth (Status and Outlook) 2023-2029


According to our LPI (LP Information) latest study, the global Cell and Gene Therapy CRO Service market size was valued at US$ million in 2022. With growing demand in downstream market, the Cell and Gene Therapy CRO Service is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.

The research report highlights the growth potential of the global Cell and Gene Therapy CRO Service market. Cell and Gene Therapy CRO Service are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cell and Gene Therapy CRO Service. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cell and Gene Therapy CRO Service market.

Cell and Gene Therapy CRO (Contract Research Organization) Service refers to a service offered by a third-party organization that specializes in providing research and development support to companies involved in cell and gene therapy. This service may include cell line development, preclinical testing, clinical trial management, regulatory services, and product manufacturing to facilitate the development and commercialization of cell and gene therapies.

Key Features:

The report on Cell and Gene Therapy CRO Service market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Cell and Gene Therapy CRO Service market. It may include historical data, market segmentation by Type (e.g., Preclinical CRO, Clinical Stage CRO), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cell and Gene Therapy CRO Service market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Cell and Gene Therapy CRO Service market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Cell and Gene Therapy CRO Service industry. This include advancements in Cell and Gene Therapy CRO Service technology, Cell and Gene Therapy CRO Service new entrants, Cell and Gene Therapy CRO Service new investment, and other innovations that are shaping the future of Cell and Gene Therapy CRO Service.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cell and Gene Therapy CRO Service market. It includes factors influencing customer ' purchasing decisions, preferences for Cell and Gene Therapy CRO Service product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cell and Gene Therapy CRO Service market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cell and Gene Therapy CRO Service market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cell and Gene Therapy CRO Service market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cell and Gene Therapy CRO Service industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cell and Gene Therapy CRO Service market.

Market Segmentation:

Cell and Gene Therapy CRO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
Preclinical CRO
Clinical Stage CRO
Others

Segmentation by application
Hospital
Research Institute
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PPD
Medpace
Labcorp
Veristat
Charles River Laboratories
Premier Research
Catalent
IQVIA
Vial
Noble Life Sciences
Ergomed

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

113 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy CRO Service Market Size 2018-2029
2.1.2 Cell and Gene Therapy CRO Service Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell and Gene Therapy CRO Service Segment by Type
2.2.1 Preclinical CRO
2.2.2 Clinical Stage CRO
2.2.3 Others
2.3 Cell and Gene Therapy CRO Service Market Size by Type
2.3.1 Cell and Gene Therapy CRO Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell and Gene Therapy CRO Service Market Size Market Share by Type (2018-2023)
2.4 Cell and Gene Therapy CRO Service Segment by Application
2.4.1 Hospital
2.4.2 Research Institute
2.4.3 Others
2.5 Cell and Gene Therapy CRO Service Market Size by Application
2.5.1 Cell and Gene Therapy CRO Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell and Gene Therapy CRO Service Market Size Market Share by Application (2018-2023)
3 Cell and Gene Therapy CRO Service Market Size by Player
3.1 Cell and Gene Therapy CRO Service Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy CRO Service Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy CRO Service Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy CRO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy CRO Service by Regions
4.1 Cell and Gene Therapy CRO Service Market Size by Regions (2018-2023)
4.2 Americas Cell and Gene Therapy CRO Service Market Size Growth (2018-2023)
4.3 APAC Cell and Gene Therapy CRO Service Market Size Growth (2018-2023)
4.4 Europe Cell and Gene Therapy CRO Service Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell and Gene Therapy CRO Service Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cell and Gene Therapy CRO Service Market Size by Country (2018-2023)
5.2 Americas Cell and Gene Therapy CRO Service Market Size by Type (2018-2023)
5.3 Americas Cell and Gene Therapy CRO Service Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy CRO Service Market Size by Region (2018-2023)
6.2 APAC Cell and Gene Therapy CRO Service Market Size by Type (2018-2023)
6.3 APAC Cell and Gene Therapy CRO Service Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell and Gene Therapy CRO Service by Country (2018-2023)
7.2 Europe Cell and Gene Therapy CRO Service Market Size by Type (2018-2023)
7.3 Europe Cell and Gene Therapy CRO Service Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy CRO Service by Region (2018-2023)
8.2 Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell and Gene Therapy CRO Service Market Forecast
10.1 Global Cell and Gene Therapy CRO Service Forecast by Regions (2024-2029)
10.1.1 Global Cell and Gene Therapy CRO Service Forecast by Regions (2024-2029)
10.1.2 Americas Cell and Gene Therapy CRO Service Forecast
10.1.3 APAC Cell and Gene Therapy CRO Service Forecast
10.1.4 Europe Cell and Gene Therapy CRO Service Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy CRO Service Forecast
10.2 Americas Cell and Gene Therapy CRO Service Forecast by Country (2024-2029)
10.2.1 United States Cell and Gene Therapy CRO Service Market Forecast
10.2.2 Canada Cell and Gene Therapy CRO Service Market Forecast
10.2.3 Mexico Cell and Gene Therapy CRO Service Market Forecast
10.2.4 Brazil Cell and Gene Therapy CRO Service Market Forecast
10.3 APAC Cell and Gene Therapy CRO Service Forecast by Region (2024-2029)
10.3.1 China Cell and Gene Therapy CRO Service Market Forecast
10.3.2 Japan Cell and Gene Therapy CRO Service Market Forecast
10.3.3 Korea Cell and Gene Therapy CRO Service Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy CRO Service Market Forecast
10.3.5 India Cell and Gene Therapy CRO Service Market Forecast
10.3.6 Australia Cell and Gene Therapy CRO Service Market Forecast
10.4 Europe Cell and Gene Therapy CRO Service Forecast by Country (2024-2029)
10.4.1 Germany Cell and Gene Therapy CRO Service Market Forecast
10.4.2 France Cell and Gene Therapy CRO Service Market Forecast
10.4.3 UK Cell and Gene Therapy CRO Service Market Forecast
10.4.4 Italy Cell and Gene Therapy CRO Service Market Forecast
10.4.5 Russia Cell and Gene Therapy CRO Service Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy CRO Service Forecast by Region (2024-2029)
10.5.1 Egypt Cell and Gene Therapy CRO Service Market Forecast
10.5.2 South Africa Cell and Gene Therapy CRO Service Market Forecast
10.5.3 Israel Cell and Gene Therapy CRO Service Market Forecast
10.5.4 Turkey Cell and Gene Therapy CRO Service Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy CRO Service Market Forecast
10.6 Global Cell and Gene Therapy CRO Service Forecast by Type (2024-2029)
10.7 Global Cell and Gene Therapy CRO Service Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 PPD
11.1.1 PPD Company Information
11.1.2 PPD Cell and Gene Therapy CRO Service Product Offered
11.1.3 PPD Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 PPD Main Business Overview
11.1.5 PPD Latest Developments
11.2 Medpace
11.2.1 Medpace Company Information
11.2.2 Medpace Cell and Gene Therapy CRO Service Product Offered
11.2.3 Medpace Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Medpace Main Business Overview
11.2.5 Medpace Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Cell and Gene Therapy CRO Service Product Offered
11.3.3 Labcorp Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 Veristat
11.4.1 Veristat Company Information
11.4.2 Veristat Cell and Gene Therapy CRO Service Product Offered
11.4.3 Veristat Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Veristat Main Business Overview
11.4.5 Veristat Latest Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Information
11.5.2 Charles River Laboratories Cell and Gene Therapy CRO Service Product Offered
11.5.3 Charles River Laboratories Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Charles River Laboratories Main Business Overview
11.5.5 Charles River Laboratories Latest Developments
11.6 Premier Research
11.6.1 Premier Research Company Information
11.6.2 Premier Research Cell and Gene Therapy CRO Service Product Offered
11.6.3 Premier Research Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Premier Research Main Business Overview
11.6.5 Premier Research Latest Developments
11.7 Catalent
11.7.1 Catalent Company Information
11.7.2 Catalent Cell and Gene Therapy CRO Service Product Offered
11.7.3 Catalent Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Catalent Main Business Overview
11.7.5 Catalent Latest Developments
11.8 IQVIA
11.8.1 IQVIA Company Information
11.8.2 IQVIA Cell and Gene Therapy CRO Service Product Offered
11.8.3 IQVIA Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 IQVIA Main Business Overview
11.8.5 IQVIA Latest Developments
11.9 Vial
11.9.1 Vial Company Information
11.9.2 Vial Cell and Gene Therapy CRO Service Product Offered
11.9.3 Vial Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Vial Main Business Overview
11.9.5 Vial Latest Developments
11.10 Noble Life Sciences
11.10.1 Noble Life Sciences Company Information
11.10.2 Noble Life Sciences Cell and Gene Therapy CRO Service Product Offered
11.10.3 Noble Life Sciences Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Noble Life Sciences Main Business Overview
11.10.5 Noble Life Sciences Latest Developments
11.11 Ergomed
11.11.1 Ergomed Company Information
11.11.2 Ergomed Cell and Gene Therapy CRO Service Product Offered
11.11.3 Ergomed Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Ergomed Main Business Overview
11.11.5 Ergomed Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us